1. Home
  2. ELTX vs PETS Comparison

ELTX vs PETS Comparison

Compare ELTX & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$3.03

Market Cap

81.2M

Sector

Health Care

ML Signal

HOLD

Logo PetMed Express Inc.

PETS

PetMed Express Inc.

N/A

Current Price

$1.74

Market Cap

41.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
ELTX
PETS
Founded
2011
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail-Drug Stores and Proprietary Stores
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
81.2M
41.7M
IPO Year
2014
2003

Fundamental Metrics

Financial Performance
Metric
ELTX
PETS
Price
$3.03
$1.74
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$18.00
N/A
AVG Volume (30 Days)
256.7K
98.9K
Earning Date
05-12-2026
06-09-2026
Dividend Yield
N/A
N/A
EPS Growth
39.29
N/A
EPS
N/A
N/A
Revenue
$2,301,000.00
$273,800,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.66
$1.57
52 Week High
$16.00
$4.10

Technical Indicators

Market Signals
Indicator
ELTX
PETS
Relative Strength Index (RSI) 40.01 32.89
Support Level $2.72 $1.70
Resistance Level $3.28 $1.87
Average True Range (ATR) 0.17 0.05
MACD 0.15 -0.02
Stochastic Oscillator 58.93 5.14

Price Performance

Historical Comparison
ELTX
PETS

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

About PETS PetMed Express Inc.

PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.

Share on Social Networks: